理化学研究所ライフサイエンス技術基盤研究センター RIKEN Center for Life Science Technologies

トピックス一覧

  • 研究成果

    CLSTから発表された最新の研究成果をご紹介します。
  • おしらせ

    受賞や協定の締結など、CLSTからのお知らせを掲載します。
  • イベント

    セミナーやシンポジウムなど、各種イベントをご紹介します。

一般の方へ

一人でも多くの方にCLSTの研究を知っていただくために、4つのコンテンツを集めました。
「読む」では研究者のインタビューや講演録などの記事を、「視聴する」では動画をご覧いただけます。「会いに行く」では、実際に研究者と会って話せるイベントをご案内します。「勉強する」は、研究内容をもっと深く知りたい方向けのコンテンツです。
  • 読む
  • 会いに行く
  • 視聴する
  • 勉強する

健康病態科学研究チーム _論文リスト一覧

健康・病態科学研究チーム

1

A voxel-based analysis of brain activity in high-order trigeminal pathway in the rat induced by cortical spreading depression.

Cui YL, Toyoda H, Sako T, Onoe K, Hayashinaka E, Wada Y, Yokoyama C, Onoe H, Kataoka Y, Watanabe Y.
Neuroimage, 108, 17-22 (2015).
2

Quantitative evaluation of mMate1 function based on minimally invasive measurement of tissue concentration using PET with [11C]Metformin in mouse.

Shingaki T, Hume WE, Takashima T, Katayama Y, Okauchi T, Hayashinaka E, Wada Y, Cui Y, Kusuhara H, Sugiyama Y, Watanabe Y.
Pharm Res, in press, (2015).
3

11C-Labeled Capsaicin and Its in Vivo Molecular Imaging in Rats by Positron Emission Tomography

Goto M, Mizuma H, Wada Y, Suzuki M, Watanabe Y, Onoe H, and Doi H.
Food Nutr Sci, 6(2), 216-220 (2015).
4

Role of cortical spreading depression in the pathophysiology of migraine

Cui YL, Kataoka Y, Watanabe Y.
Neurosci Bull, 30(5), 812-822 (2014).
5

Fatigue correlates with the decrease in parasympathetic sinus modulation induced by a cognitive challenge

Mizuno K, Tajima K, Watanabe Y, Kuratsune H.
Behav Brain Funct, 10, 25 (2014).
7

Efficient syntheses of [C-11]zidovudine and its analogs by convenient one-pot palladium(0)-copper(I) co-mediated rapid C-[C-11]methylation

Zhang ZE, Doi H, Koyama H, Watanabe Y, Suzuki M.
J Label Compd Radiopharm, 57(8), 540-549 (2014).
8

[11C]Cetrozole: an Improved C-[11C]Methylated PET Probe for Aromatase Imaging in the Brain.

Takahashi K, Hosoya T, Onoe K, Doi H, Nagata H, Hiramatsu T, Li XL, Watanabe Y, Wada Y, Takashima T, Suzuki M, Onoe H, Watanabe Y.
J Nucl Med, 55(5), 852-857 (2014).
9

PET Imaging Analysis with 64Cu in Disulfiram Treatment for Aberrant Copper Bio-distribution in Menkes Disease Mouse Model

Nomura S, Nozaki S, Hamazaki T, Takeda T, Ninomiya E, Kudo S, Hayashinaka E, Wada Y, Hiroki T, Fujisawa C, Kodama H, Shintaku H, Watanabe Y.
J Nucl Med, 55(5), 845-851 (2014).
10

Quantitative evaluation of the improvement in the pharmacokinetics of a nucleic acid drug delivery system by dynamic PET imaging with F-18-incorporated oligodeoxynucleotides

Mukai H, Ozaki D, Cui Y, Kuboyama T, Yamato-Nagata H, Onoe K, Takahashi M, Wada Y, Imanishi T, Kodama T, Obika S, Suzuki M, Doi H, Watanabe Y.
J Control Release, 180, 92-99 (2014).
11

Human whole-body biodistribution and dosimetry of a new PET tracer, [(11)C]ketoprofen methyl ester, for imagings of neuroinflammation.

Ohnishi A, Senda M, Yamane T, Sasaki M, Mikami T, Nishio T, Ikari Y, Nishida H, Shukuri M, Takashima T, Mawatari A, Doi H, Watanabe Y, Onoe H
Nucl Med Biol, 41(7), 594-599 (2014).
12

Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: an 11C-(R)-PK11195 PET study.

Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, Onoe K, Fukuda S, Kawabe J, Takahashi K, Kataoka Y, Shiomi S, Yamaguti K, Inaba M, Kuratsune H, Watanabe Y.
J Nucl Med, 55(6), 945-950 (2014).
13

Brain Interleukin-1 beta and the Intrinsic Receptor Antagonist Control Peripheral Toll-Like Receptor 3-Mediated Suppression of Spontaneous Activity in Rats

Yamato M, Tamura Y, Eguchi A, Kume S, Miyashige Y, Nakano M, Watanabe Y, Kataoka Y.
PLoS One, 9(3), e90950 (2014).
14

The synthesis and biodistribution of [C-11]metformin as a PET probe to study hepatobiliary transport mediated by the multi-drug and toxin extrusion transporter 1 (MATE1) in vivo

Hume WE, Shingaki T, Takashima T, Hashizume Y, Okauchi T, Katayama Y, Hayashinaka E, Wada Y, Kusuhara H, Sugiyama Y, Watanabe Y.
Bioorg Med Chem, 21(24), 7584-7590 (2013).
15

Positron emission tomography study on pancreatic somatostatin receptors in normal and diabetic rats with Ga-68-DOTA-octreotide: A potential PET tracer for beta cell mass measurement

Sako T, Hasegawa K, Nishimura M, Kanayama Y, Wada Y, Hayashinaka E, Cui YL, Kataoka Y, Senda M, Watanabe Y.
Biochem Biophys Res Commun, 442(1-2), 79-84 (2013).
16

64Cu-DOTA-trastuzumab PET imaging in patients with HER2-positive breast cancer.

Tamura K, Kurihara H, Yonemori K, Tsuda H, Suzuki J, Kono Y, Honda N, Kodaira M, Yamamoto H, Yunokawa M, Shimizu C, Hasegawa K, Kanayama Y, Nozaki S, Kinoshita T, Wada Y, Tazawa S, Takahashi K, Watanabe Y, Fujiwara Y.
J Nucl Med, 54(11), 1869-1875 (2013).
17

Investigation of the Effect of Active Efflux at the Blood-Brain Barrier on the Distribution of Nonsteroidal Aromatase Inhibitors in the Central Nervous System

Miyajima, M; Kusuhara, H; Takahashi, K; Takashima, T; Hosoya, T; Watanabe, Y; Sugiyama, Y
J Pharm Sci, 102(9), 3309-3319 (2013).
19

Synthesis of an 11C-Labeled Antiprion GN8 Derivative and Evaluation of Its Brain Uptake by Positron Emission Tomography

Kimura T, Sako T, Siqin, Hosokawa-Muto J, Cui YL, Wada Y, Kataoka Y, Doi H, Sakaguchi S, Suzuki M, Watanabe Y, Kuwata K.
ChemMedChem, 8(7), 1035-1039 (2013).
20

Dynamic analysis of fluid distribution in the gastrointestinal tract in rats: positron emission tomography imaging after oral administration of nonabsorbable marker, [(18)F]Deoxyfluoropoly(ethylene glycol).

Takashima T, Shingaki T, Katayama Y, Hayashinaka E, Wada Y, Kataoka M, Ozaki D, Doi H, Suzuki M, Ishida S, Hatanaka K, Sugiyama Y, Akai S, Oku N, Yamashita S, Watanabe Y
Mol Pharm, 10(6), 2261-2269 (2013).
21

A conformationally fixed analog of the peptide mimic Grb2-SH2 domain: synthesis and evaluation against the A431 cancer cell.

Iwata T, Tanaka K, Tahara T, Nozaki S, Onoe H, Watanabe Y, Fukase K.
Mol Biosyst, 9(5), 1019-1025 (2013).
22

Endogenous compounds labeled with radionuclides of short half-life—some perspectives.

Långström B, Karimi F, Watanabe Y.
J Labelled Compd Rad, 56(3-4), 251-262 (2013).
23

Neurocognitive impairment in childhood chronic fatigue syndrome.

Mizuno K, Watanabe Y.
Front Physiol, 4, 87 (2013).
24

Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice.

Nakamura I, Hasegawa K, Wada Y, Hirase T, Node K, Watanabe Y.
Biochem Biophys Res Commun, 433(1), 47-51 (2013).
26

Novel Molecular Imaging of Atherosclerosis With Gallium-68-Labeled Apolipoprotein A-I Mimetic Peptide and Positron Emission Tomography

Kawachi E, Uehara Y, Hasegawa K, Yahiro E, Ando S, Wada Y, Yano T, Nishikawa H, Shiomi M, Miura S, Watanabe Y, Saku K.
Circ J, 77(6), 1482-1489 (2013).
27

Imaging of gastrointestinal absorption and biodistribution of an orally administered probe using positron emission tomography in humans.

Shingaki T, Takashima T, Wada Y, Tanaka M, Kataoka M, Ishii A, Shigihara Y, Sugiyama Y, Yamashita S, Watanabe Y.
Clin Pharmacol Ther, 91(4), 653-659 (2012).

和文論文

CLSTは、2018年4月1日からの理化学研究所第4期中期計画により、3つのセンターに改組されました。健康・病態科学研究チームの最新の情報は、下記よりご覧いただけます。


▶ 生命機能科学研究センター 健康・病態科学研究チーム [http://www.bdr.riken.jp/jp/research/labs/watanabe-y-health/index.html]